10th Mar 2022 15:57
MaxCyte Inc - Maryland-based platform for cell-based research - Hires Cenk Sumen as chief scientific officer. Sumen joins from San Diego, California-based hair-loss treatment firm Stemson Therapeutics Corp, where he was chief technology officer.
Current stock price: 420.00 pence
12-month change: down 51%
By Tom Waite; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
MaxCyte